New cysteine protease inhibitors in physiological secretory fluids and their medical significance

By Katunuma N.   Ohashi A.   Sano E.   Murata E.   Shiota H.   Yamamoto K.   Majima E.   Le Q.T.  

Advances in Enzyme Regulation, Vol. 43, Iss. 1, 2003-06 ,pp. : 393-410

Elsevier

Access to resources Recommend Favorite

Hepatitis C NS3 protease inhibition by peptidyl- -ketoamide inhibitors: kinetic mechanism and structure

By Liu Y.   Stoll V.S.   Richardson P.L.   Saldivar A.   Klaus J.L.   Molla A.   Kohlbrenner W.   Kati W.M.  

Archives of Biochemistry and Biophysics, Vol. 421, Iss. 2, 2004-01 ,pp. : 207-216

Elsevier

Access to resources Recommend Favorite

Fluorobenzoyl dipeptidyl derivatives as inhibitors of the Fasciola hepatica cysteine protease cathepsin L1

By Moran Brian W.   Anderson Frankie P.   Ruth Deborah M.   Fágáin Ciarán Ó.   Dalton John P.   Kenny Peter T. M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 1, 2010-02 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Systematic Optimization of Expression and Refolding of the Plasmodium falciparum Cysteine Protease Falcipain-2

By Sijwali P.S.   Brinen L.S.   Rosenthal P.J.  

Protein Expression and Purification, Vol. 22, Iss. 1, 2001-06 ,pp. : 128-134

Academic Press

Access to resources Recommend Favorite

Novel Application of Peptidyl-Lys Metallopeptidase as a C-Terminal Processing Protease

By  

Protein and Peptide Letters, Vol. 23, Iss. 4, 2016-04 ,pp. : 396-403

Bentham Science Publishers

Access to resources Recommend Favorite